Associated Papers
Mouse tumor susceptibility genes identify drug combinations for multiple myeloma.
Zhang S et al.
Journal of Cancer Metastasis and Treatment, 2020
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S et al.
Proceedings of the National Academy of Sciences of the United States of America, 1998
Select a paper to view details